» Authors » Rong-Nan Chien

Rong-Nan Chien

Explore the profile of Rong-Nan Chien including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 209
Citations 2447
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang M, Cheng J, Chen W, Shen Y, Kuo C, Chien R
Oncoimmunology . 2025 Feb; 14(1):2470128. PMID: 40008547
How mixed cryoglobulinemia (MC) affects cancer risk in chronic hepatitis C patients with sustained virologic response (SVR) remains unclear. In a 12-year prospective study, post-SVR MC was assessed every 3‒6 ...
2.
Dongelmans E, Hirode G, Hansen B, Chen C, Su T, Seto W, et al.
J Hepatol . 2025 Jan; 82(3):446-455. PMID: 39773379
Background & Aims: Flares after nucleos(t)ide analogue (NA) cessation are common and potentially harmful. Predictors of flares are required for risk stratification and to guide off-treatment follow-up. Method: This multicenter...
3.
Wu J, Chen W, Huang C, Chen Y, Hsu C, Chien R, et al.
Hepatol Int . 2024 Dec; 19(1):118-130. PMID: 39699792
Background: The phenotype of cryoglobulinemia in hepatitis B virus (HBV) carriers remains elusive. Methods: A 7-year prospective cohort of 648 hepatitis B e antigen (HBeAg)-negative Taiwanese HBV carriers [males: 344...
4.
Huang J, Chang T, Yeh M, Shen F, Tai C, Chen J, et al.
Hepatol Commun . 2024 Oct; 8(11). PMID: 39470335
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide, affecting >30% of the global population. Metabolic dysregulation, particularly insulin resistance and its subsequent manifestation as...
5.
Chen C, Shan Cheng J, Chen T, Kuo C, Ku H, Chien R, et al.
Clin Colorectal Cancer . 2024 Sep; 24(1):39-47.e1. PMID: 39341699
Background: Whether HCV infection is associated with colorectal cancer (CRC) development remains inconclusive. Methods: A nationwide population-based cohort study of the Taiwan National Health Insurance Research Database was conducted. Results:...
6.
Kao Y, Liu Y, Cheng Y, Wen Y, Hsieh Y, Hsu C, et al.
Viruses . 2024 Sep; 16(9). PMID: 39339961
Background: Hepatocellular carcinoma (HCC) remains a significant concern for patients with chronic hepatitis C (HCV), even after achieving a sustained virological response (SVR) with direct-acting antivirals (DAAs) or interferon (IFN)-based...
7.
Chang M, Le P, Chen W, Chen T, Su C, Chen C, et al.
J Gastroenterol Hepatol . 2024 Sep; 39(12):2835-2844. PMID: 39307997
Background And Aim: The characteristics of autoimmune liver diseases (AILDs), including primary biliary cholangitis (PBC), autoimmune hepatitis (AIH), and PBC-AIH overlap syndrome (OS), have rarely been investigated and compared in...
8.
Chien C, Chou T, Chen L, Lin C, Chang J, Liu C, et al.
Microorganisms . 2024 Jul; 12(7). PMID: 39065170
The optimal strategy for the microelimination of HCV within community settings remains ambiguous. We evaluated the percentage of participants who achieved linkage to care (LTC) following the conclusion of a...
9.
Peng K, Chang M, Chien R, Chen Y, Tian Y, Peng Y, et al.
J Clin Med . 2024 Jul; 13(13). PMID: 38999366
: Patients with cirrhosis are susceptible to sepsis and septic shock. Cirrhotic patients also have increased capillary permeability and are prone to developing volume overload. Patients with septic shock may...
10.
Jeng W, Chien R, Liaw Y
Hepatology . 2024 Jun; 80(5):E76-E77. PMID: 38836640
No abstract available.